Page 82 - 80_03

Envejecimiento
cerebral
normal
y
patológico
…

34:
Tolnay,
M.;
Calhoun,
M.;
Pham,
H.
C.;
Egensperger,
R.;
Probst.
A
Low
amyloid
(Abeta)

plaque
load
and
relative
predominance
of
diffuse
plaques
distinguish
argyrophilic
grain

disease
from
Alzheimer's
disease.
Neuropathol
Appl
Neurobiol
25,
295-­-305
(1999).

35:
Ince,
P.;
Irving,
D.;
MacArthur,
F.;
Perry,
R.
H.
Quantitative
neuropathological
study
of

Alzheimer-­-type
pathology
in
the
hippocampus:
comparison
of
senile
dementia
of

Alzheimer
type,
senile
dementia
of
Lewy
body
type,
Parkinson's
disease
and
non-­-
demented
elderly
control
patients.
J
Neurol
Sci.
106,142-­-152
(1991).

36
Mesulam,
M.
M.;
Weintraub,
S.;
Rogalski,
E.
J.;
Wieneke,
C.;
Geula,
C.;
Bigio,
E.
H.
Asymmetry

and
heterogeneity
of
Alzheimer's
and
frontotemporal
pathology
in
primaryprogressive

aphasia.
Brain
(en
prensa)
(2014).

37.
Panza,
F.;
Frisardi,
V.;
Capurso,
C.;
D'Introno,
A.;
Colacicco,
A.
M.;
Imbimbo,
B.
P.;
Santamato,

A.;
Vendemiale,
G.;
Seripa,
D.;
Pilotto,
A.;
Capurso,
A.;
Solfrizzi,
V.;
Late-­-life
depression,
mild

cognitive
impairment,
and
dementia:
possible
continuum?
Am
J
Geriatr
Psychiatr

18,
98-­-
116
(2010).

38.
Wadsworth,
L.P.;
Lorius,
N.;
Donovan,
N.J.;
Locascio,
J.
J.;
Rentz,
D.
M.;
Johnson,
K.
A.;

Sperling,
R.
A.;
Marshall,
G.A.
Neuropsychiatric
symptoms
and
global
functional

impairment
along
the
Alzheimer's
continuum.
Dement
Geriatr
Cogn
Disord
34,
96-­-111

(2012).

39.
Zhang,
M.;
Wang,
H.;
Li,
T.;
Yu,
X.
Prevalence
of
neuropsychiatric
symptoms
across
the

declining
memory
continuum:
an
observational
study
in
a
memory
clinic
setting.
Dement

Geriatr
Cogn
Dis
Extra

2,
200-­-208
(2012).

40.
Rami,
L.;
Fortea,
J.;
Bosch,
B.;
Solé-­-Padullés,
C.;
Lladó,
A.;
Iranzo,
A.;
Sánchez-­-Valle,
R.;

Molinuevo,
J.
L.
Cerebrospinal
fluid
biomarkers
and
memory
present
distinct
associations

along
the
continuum
from
healthy
subjects
to
AD
patients.
J
Alz
Dis
23,
319-­-26
(2011).

41.
Hyman,
B.
T.;
Phelps,
C.
H.;
Beach,
T.
G.;
Bigio,
E.
H.;
Cairns,
N.
J.;
Carrillo,
M.
C.;
Dickson,
D.

W.;
Duyckaerts,
C.;
Frosch,
M.
P.;
Masliah,
E.;
Mirra,
S.
S.;
Nelson,
P.
T.;
Schneider,
J.A.;
Thal,

D.R.;
Thies,
B.;
Trojanowski,
J.
Q.;
Vinters,
H.V.,
Montine,
T.J.
National
Institute
on
Aging-­-
Alzheimer's
Association
guidelines
for
the
neuropathologic
assessment
of
Alzheimer's

disease.
Alzheimers
Dement.
Dis.
8,
1-­-13
(2012).

42.
Town,
T.;
Nikolic,
V.;
Tan,
J.
The
microglial
"activation"
continuum:
from
innate
to
adaptive

responses.
J
Neuroinflammation

31,
2-­-24
(2005).

43.
Thal,
D.
R.;
Rüb,
U.;
Orantes,
M.;
Braak,
H.
Phases
of
Abeta
deposition
in
the
human
brain

and
its
relevance
for
the
development
of
AD.
Neurology
58,
1791-­-1800
(2002).

44.
Braak,
H.;
Braak,
E.
Neuropathological
stageing
of
Alzheimer-­-related
changes.
Acta

Neuropathol

82,
239-­-259
(1991).

45.
Nelson,
P.
T.;
Alafuzoff,
I.;
Bigio,
E.
H.;
Bouras,
C.;
Braakm,
H.;
Cairns,
N.
J:,
Castellani,
R.
J.;

Crain,
B.
J.;
Davies,
P.;
Del
Tredici,
K.;
Duyckaerts,
C.;
Frosch,
M.
P.;
Haroutunian,
V.;
HofPR.;

Hulette,
C.M.;
Hyman,
B.T.;
Iwatsubo,
T.;
Jellinger,
K.
A.;
Jicha,
G.
A.;
Kövari,
E.;
Kukull,
W.
A.;

Leverenz,
J.
B.;
Love,
S.;
Mackenzie,
I.
R.;
Mann,
D.
M.;
Masliah,
E.;
McKee,
A.
C.;
Montine,
T.

J.;
Morris,
J.
C.;
Schneider,
J.
A.;
Sonnen,
J.
A.;
Thal,
D.
R.;
Trojanowski,
J.
Q.;
Troncoso,
J.
C.;

Wisniewski,
T.;
Woltjer,
R.
L.;
Beach,
T.
G.
Correlation
of
Alzheimer
disease

neuropathologic
changes
with
cognitive
status:
a
review
of
the
literature.
J
Neuropathol

Exp
Neurol
71,
362-­-381
(2012).

46.

Josephs,
K.
A.;
Whitwell,
J.
L.;
Ahmed,
Z.;
Shiung,
M.
M.;
Weigand,
S.
D.;
Knopman,
D.
S.;

Boeve,
B.
F.;
Parisi,
J.
E.;
Petersen,
R.
C.;
Dickson,
D.
W.;
Jack,
C.R.;
Jr.
Beta-­-amyloid
burden

is
not
associated
with
rates
of
brain
atrophy.
Ann
Neurol
63,
204-­-12
(2008).

47
Toga,
A.
W.
The
clinical
value
of
large
neuroimaging
data
sets
in
Alzheimer's
disease.

Neuroimaging
Clin
N
Am

22,
107-­-118
(2012).

48.
Wirth,
M.;
Villeneuve,
S.;
Haase,
C.
M.;
Madison,
C.
M.;
Oh,
H.;
Landau,
S.
M.;
Rabinovici,
G.
D.;

Jagust,
W.
J.
Associations
between
Alzheimer
disease
biomarkers,
neurodegeneration,
and

cognition
in
cognitively
normal
older
people.
JAMA
Neurol.
70,1512-­-1519
(2013)

49.
Panza,
F.;
Frisardi,
V.;
Capurso,
C.;
D'Introno,
A.;
Colacicco,
A.
M.;
Chiloiro,
R.;
Dellegrazie;
F.;

Di
Palo,
A.;
Capurso,
A.;
Solfrizzi,
V.
Effect
of
donepezil
on
the
continuum
of
depressive

symptoms,
mild
cognitive
impairment,
and
progression
to
dementia.
J
Am
Geriatr
Soc
58,

389-­-390
(2010).

50.
Wright,
L.
K.;
Litaker,
M.;
Laraia,
M.
T.;
DeAndrade,
S.
Continuum
of
care
for
Alzheimer's

disease:
a
nurse
education
and
counseling
program.
Issues
Ment
Health
Nurs
22,
231-­-252

(2001).

535